DETERMINATION OF GENETIC POLYMORPHISMS OF THE DIHYDROPYRIMIDINE DEHYDROGENASE GENE IN REAL CLINICAL PRACTICE AS PREDICTORS OF SEVERE FLUOROPYRIMIDINE ASSOCIATED TOXICITY